Access to Medicines for Treating People With Cryptococcal Meningitis. (29th August 2022)

• Record Type: Journal Article
• Authors: Burry, Jessica; Casas, Carmen Perez; Ford, Nathan
• Is Part Of: Clinical infectious diseases. Volume 76:Number 3(2023)
• Page Start: e773
• Page End: e775
• Publication Date: 2022-08-29
• Subjects: access -- cryptococcal meningitis -- HIV/AIDS -- liposomal amphotericin B -- mortality; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciac689
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Cryptococcal meningitis accounts for 1 in 5 AIDS-related deaths globally. World Health Organization guidelines strongly recommend a single high dose of liposomal amphotericin B as part of preferred treatment, but this drug remains unaffordable in most low- and middle-income countries. A proactive approach is needed from manufacturers and other stakeholders to improve access.